En Es
Categories

Industry News

PENTAX Medical Clears CE Mark for New AI-Assisted Polyp Detector

By HospiMedica International staff writers
13 Jan 2020

Image: DISCOVERY™ (Photo courtesy of PENTAX Medical)PENTAX Medical (Tokyo, Japan) has cleared CE mark for DISCOVERY, its Artificial Intelligence (AI) assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination.

PENTAX Medical, a division of HOYA Group, provides endoscopic imaging devices and solutions to the global medical community. DISCOVERY is the outcome of a close cooperation between PENTAX Medical research center located in Augsburg, Germany, and expert clinical partners from six of the leading medical institutions across the world. For this next generation development, a total of more than 120,000 files from approximately 300 clinical cases were used for the software training. By this, DISCOVERY is able to assist with the detection of potential polyps in real time. The system is built in a flat monitor to provide a high usability as it can be used with any of PENTAX Medical video endoscopy systems to highlight potential polyps. The menu is self-explaining and uses an intuitive touchscreen interface.

"The benefits for the customers are outstanding. Our vision was to bring Artificial Intelligence into the operating room in the most user-friendly way. We wanted to give doctors the possibility to use this exciting new technology to strive for a better clinical outcome and maximize the patient care," said Wolfgang Mayer, Managing Director, R&D, PENTAX Medical Augsburg.

"As endoscopists one of our major tasks is to reduce the incidence of colorectal cancer. I am very confident that the DISCOVERY will translate into increasing our own Adenoma Detection Rate and therewith will contribute to reduce colorectal cancer mortality," said Professor Timo Rath, Professor of Endoscopy and Molecular Imaging, University of Erlangen, Nuremberg, Germany.

Related Links:
PENTAX Medical



E-mail Print
FaceBook Twitter Google+ Linked in

Pentax

Provides endoscopic imaging devices and solutions
More info

More articles about Pentax

17 Jan 2017
PENTAX Medical Acquires C2 Therapeutics
PENTAX Medical, a manufacturer of medical imaging equipment, has acquired medical device company C2 Therapeutics for an undisclosed amount.
Read More

Additional news

22 Jan 2020
Global Point of Care Testing (POCT) Market to Reach USD 46.7 Billion by 2024
 The global point of care testing (POCT) market is expected to surpass USD 37 billion by 2025, driven mainly by the migration of POCT from the hospital environment to a range of medical environments, including the workplace, home, disaster care and most recently, convenience clinics. POCT now appears to be headed for a bigger role in diagnosis and monitoring patient care. Additionally, growing awareness about early disease diagnosis and prevention has stimulated the demand for POCT for detecting cancer and infectious disease in the early stages. Moreover, the rising incidence of infectious diseases and chronic conditions, such as cardiovascular diseases and diabetes in the developing countries such as India and China, is stimulating the demand for POCT services.
Read More
16 Jan 2020
Radiomic Algorithm Predicts if Patient’s Cancer Can Return 10 Years After Treatment
 A new study by researchers at Penn Medicine (Philadelphia, PA, USA) has found that Magnetic Resonance Imaging (MRI) and an emerging field of medicine called radiomics — which uses algorithms to extract a large amount of features from medical images — could help to characterize the heterogeneity of cancer cells within a tumor and allow for a better understanding of the causes and progression of a person’s individual disease.
Read More
07 Jan 2020
New AI Model Identifies Women Facing Future Risk of Breast Cancer
 Researchers from the Karolinska Institute (Stockholm, Sweden) have developed a sophisticated type of artificial intelligence (AI) which can outperform existing models at predicting which women are at future risk of breast cancer.
Read More
07 Jan 2020
Global EEG Devices Market to Reach USD 2.20 Billion in 2027
 The global EEG (Electroencephalography) devices market was valued at USD 1.12 billion in 2018 and is projected to grow at a CAGR of 7.8 % over the forecast period 2019-2027 to reach USD 2.20 billion in 2027, driven mainly by the increasing prevalence of sleep disorders.

Read More
06 Jan 2020
Google AI System Beats Doctors in Detecting Breast Cancer
 A team of researchers from Google Health (Palo Alto, CA, USA) have developed an artificial intelligence (AI) model which can spot breast cancer in de-identified screening mammograms (where identifiable information has been removed) with greater accuracy, fewer false positives, and fewer false negatives than experts. This can find future applications wherein the model could support radiologists performing breast cancer screenings.
Read More
03 Jan 2020
Nova Biomedical Launches New BioProfile FLEX2 On-Line Autosampler
 Nova Biomedical (Waltham, MA, USA) has launched the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to three weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests, including pH, gases, metabolites, osmolality, cell density, and cell viability.
Read More
03 Jan 2020
Global Hematology Diagnostic Devices and Equipment Market to Reach USD 2.35 Billion by 2022
 The global hematology diagnostic devices and equipment market was valued at about USD 1.9 billion in 2018 and is projected to grow to at a CAGR of 5.5% to USD 2.35 billion in 2022. The market growth is driven mainly by an increase in the use of hematology diagnostic devices due to the rising prevalence of blood disorders which affect millions of people each year across the world, irrespective of age, race, and sex.
Read More
03 Jan 2020
Global Immunochemistry Diagnostic Devices and Equipment Market to Reach USD 19.24 Billion by 2022
 The global immunochemistry diagnostic devices and equipment market was valued at about USD 16.7 billion in 2018 and is projected to grow at a CAGR of 3.6% to USD 19.24 billion in 2022. The market growth will be driven by an increase in the incidence of target diseases, such as viral infections, cardiovascular diseases, cancer or hormonal disorders worldwide, mainly due to poor lifestyle choices.
Read More
02 Jan 2020
AI Outperforms Radiologists in Detecting Tiny Brain Hemorrhages on CT Scans
 Scientists at UC San Francisco (San Francisco, CA, USA) and UC Berkeley (Berkeley, CA, USA) have developed an algorithm that performed better than two out of four expert radiologists in finding tiny brain hemorrhages in head scans. The algorithm could help doctors treat patients with traumatic brain injuries (TBI), strokes and aneurysms.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions